Monthly Archives: February 2018

SECOND OPINION | Exaggerated benefit found in 1 out of 3 early trials

This is an excerpt from Second Opinion, a weekly roundup of eclectic and under-the-radar health and medical science news emailed to subscribers every Saturday morning. If you haven’t subscribed yet, you can do that by clicking here. A new drug or medical device might show a promising benefit in the first trial, and even in the second trial. But for some mysterious reason that treatment effect ...

Read More »